Allegra Leghissa Joins Cannabis Science and Technology’s Editorial Advisory Board
Cannabis Science and Technology is pleased to announce the addition of Allegra Leghissa, PhD, to its editorial advisory board (EAB).
Allegra Leghissa, PhD
Cannabis Science and Technology is pleased to announce the addition of Allegra Leghissa, PhD, to its editorial advisory board (EAB).
Dr. Allegra Leghissa graduated from the University of Bologna, Italy with an undergraduate degree in Chemistry in 2014 and a PhD in analytical chemistry from the University of Texas, Arlington in 2018. Under the supervision of Professor Kevin Schug, she worked on the analysis of terpenes and cannabinoids in cannabis and specifically delta-9-THC metabolites by gas chromatography–tandem mass spectrometry (GC–MS/MS). She also had some experience with the analysis of these components by liquid chromatography (LC)–MS/MS. Her experience in the field of cannabis testing was solidified through participation in relevant conferences and seminars.
Dr. Leghissa is currently an LC–MS/MS application engineer with Shimadzu France.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
